Kolon Biotech, Inc. announced that it issued 174,000 shares at an issue price of KRW 11,500 per share for proceeds of KRW 2,001,000,000 on March 5, 2024. The transaction included participation from returning investor, Kolon Life Science Inc. The transaction has been approved by board of directors of the company. The method of capital increase is through shareholder allocation.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
20,600 KRW | +0.24% | 0.00% | -19.84% |
1st Jan change | Capi. | |
---|---|---|
-19.84% | 18Cr | |
+56.89% | 81TCr | |
+39.52% | 62TCr | |
-6.55% | 35TCr | |
+7.92% | 29TCr | |
+13.74% | 24TCr | |
+13.83% | 22TCr | |
-0.49% | 22TCr | |
+7.94% | 17TCr | |
-2.57% | 16TCr |
- Stock Market
- Equities
- A102940 Stock
- News Kolon Life Science Inc.
- Kolon Biotech, Inc. announced that it has received KRW 2.001 billion in funding from Kolon Life Science Inc.